skip to main content

Cancer Center Leader Elected to Prestigious Institute of Medicine

Eric Fearon, M.D., Ph.D
Eric R. Fearon, M.D., Ph.D., Deputy Director of the U-M Comprehensive Cancer Center

In October, the Washington, D.C.-based Institute of Medicine (IOM) of the National Academies announced the names of 70 new members and 10 foreign associates during its 43rd annual meeting. University of Michigan Comprehensive Cancer Center Deputy Director Eric R. Fearon, M.D., Ph.D., was elected to the IOM along with James O. Woolliscroft, M.D., dean of the Medical School, and Arline T. Geronimus, Sc.D., from the School of Public Health.

Membership in the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Fearon, the Emanuel N. Maisel Professor of Oncology, of internal medicine, of human genetics and of pathology, is a nationally recognized investigator in the field of cancer genetics. His laboratory pursues research to address how cancer gene defects contribute to the development and progression of colorectal and other cancers. A major goal of the research is to develop novel strategies for prevention, early detection, and treatment of colorectal cancer.

In addition to his role as deputy director, Fearon is also associate director for basic science research at the U-M Comprehensive Cancer Center. In these roles, he works to coordinate multidisciplinary research on the mechanisms underlying cancer development, along with efforts to translate the laboratory observations to new clinical applications for improved diagnosis and management of cancer.

Fearon also serves as the division chief of Molecular Medicine & Genetics in the Department of Internal Medicine. He co-directs the CCC’s Cancer Genetics Research Program, which focuses on identifying genetic and epigenetic alterations in cancer, as well as on applying the emerging information for improvements in risk assessment, prevention, pre-symptomatic diagnosis, early detection and treatment of cancer.

With the election of Fearon, Geronimus and Woolliscroft, U-M now boasts 53 past and present members of the IOM.

Says Fearon, “I am honored to be elected to the IOM, and the recognition largely reflects the great good fortune that I have had to work with such terrific mentors, colleagues, and trainees during my career.”

Learn more

Go back to mCancerNews

back to top